Volume 29, Number 6—June 2023
CME ACTIVITY - Synopsis
Neurologic Complications of Babesiosis, United States, 2011–2021
Table 4
Associations between comorbid conditions and neurologic symptoms in patients with babesiosis admitted to Yale-New Haven Hospital, New Haven, Connecticut, USA, January 2011–October 2021*
Comorbid condition |
Confusion/delirium, no. (%) |
Adjusted odds of confusion/delirium |
Impaired consciousness, no. (%) |
Adjusted odds of impaired consciousness |
||
---|---|---|---|---|---|---|
OR (95% CI) |
p value |
OR (95% CI) |
p value |
|||
Diabetes mellitus | ||||||
No | 140 (13.6) | 1.00 | 140 (10.7) | |||
Yes |
23 (34.8) |
3.04 (1.11–8.34) |
0.031 |
23 (39.1) |
5.36 (1.98–14.48) |
<0.001 |
Stroke/transient ischemic attack | ||||||
No | 150 (14.7) | |||||
Yes | 13 (38.5) | 3.06 (0.88–10.66) | 0.079 |
*Univariate logistic regression models tested associations between the following comorbid conditions and the 3 most frequent neurologic symptoms (headache, confusion/delirium, impaired consciousness): cardiac disorder, hypertension, diabetes mellitus, immunocompromised status, stroke/transient ischemic attack, obesity, chronic kidney disease, migraine, and malignancy. Variables that were significant in unadjusted univariate analysis were entered into a multivariate model for each neurologic symptom. The significance level for univariate and multivariate analysis was set to p<0.05. Boldface indicates statistical significance.
1These first authors contributed equally to this article.
2These senior authors contributed equally to this article.